Covid-19, FDA and vaccine
Digest more
The FDA plans to limit access to certain high-risk groups and also told Pfizer and Moderna to update their warning labels about heart inflammation.
Preliminary data from researchers in China suggest the NB.1.8.1 variant is not better at evading the immune system compared to other strains on the rise, but it does have a greater ability to bind to human cells, suggesting it could be more transmissible.
Theatre nurse David Collyer wanted to shoot a documentary photography project in the last years of the Welsh hospital he worked in. Then Covid-19 appeared.
In Bengaluru, 32 of Karnataka’s 35 active cases are from the city, including a nine-month-old baby now under treatment at Vani Vilas Hospital. Health officials said infections have been steadily rising over the past 20 days and urged citizens, especially high-risk groups, to resume COVID-appropriate behaviour.
A Phoenix doctor weighs in on the potential impact of FDA plans to limit COVID booster access to high-risk groups, raising cost and care concerns.
Explore more
A class of drugs known as Janus kinase, or JAK, inhibitors, which work by slowing down the immune system, should be the first-line therapy for patients hospitalized for COVID-19, researchers reported in The Lancet Respiratory Medicine.